D.A. Davidson & Co’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.64M | Buy |
2,923
+815
| +39% | +$523K | 0.01% | 758 |
|
|
2025
Q4 | $1.43M | Buy |
2,108
+156
| +8% | +$106K | 0.01% | 777 |
|
|
2025
Q3 | $1.25M | Buy |
1,952
+108
| +6% | +$65.6K | 0.01% | 792 |
|
|
2025
Q2 | $989K | Buy |
1,844
+44
| +2% | +$21K | 0.01% | 820 |
|
|
2025
Q1 | $756K | Buy |
1,800
+126
| +8% | +$54.7K | 0.01% | 871 |
|
|
2024
Q4 | $692K | Buy |
1,674
+45
| +3% | +$19.7K | 0.01% | 907 |
|
|
2024
Q3 | $823K | Buy |
1,629
+142
| +10% | +$69K | 0.01% | 838 |
|
|
2024
Q2 | $724K | Sell |
1,487
-3
| -0.2% | -$1.51K | 0.01% | 848 |
|
|
2024
Q1 | $804K | Sell |
1,490
-19
| -1% | -$10.4K | 0.01% | 807 |
|
|
2023
Q4 | $838K | Buy |
1,509
+64
| +4% | +$30K | 0.01% | 768 |
|
|
2023
Q3 | $632K | Sell |
1,445
-4
| -0.3% | -$2K | 0.01% | 824 |
|
|
2023
Q2 | $728K | Buy |
1,449
+179
| +14% | +$85.8K | 0.01% | 796 |
|
|
2023
Q1 | $635K | Buy |
1,270
+44
| +4% | +$21.1K | 0.01% | 826 |
|
|
2022
Q4 | $500K | Buy |
1,226
+8
| +0.7% | +$3.1K | 0.01% | 845 |
|
|
2022
Q3 | $397K | Sell |
1,218
-10
| -0.8% | -$3.67K | 0.01% | 894 |
|
|
2022
Q2 | $431K | Sell |
1,228
-320
| -21% | -$130K | 0.01% | 872 |
|
|
2022
Q1 | $847K | Buy |
1,548
+21
| +1% | +$11K | 0.01% | 702 |
|
|
2021
Q4 | $1M | Sell |
1,527
-23
| -1% | -$14.4K | 0.01% | 655 |
|
|
2021
Q3 | $964K | Buy |
1,550
+3
| +0.2% | +$2.02K | 0.01% | 644 |
|
|
2021
Q2 | $977K | Sell |
1,547
-22
| -1% | -$12.1K | 0.01% | 637 |
|
|
2021
Q1 | $768K | Buy |
+1,569
| New | +$786K | 0.01% | 666 |
|
|
2020
Q2 | – | Sell |
-1,166
| Closed | -$282K | – | 981 |
|
|
2020
Q1 | $282K | Buy |
1,166
+50
| +4% | +$13K | 0.01% | 769 |
|
|
2019
Q4 | $291K | Buy |
1,116
+81
| +8% | +$21.3K | ﹤0.01% | 827 |
|
|
2019
Q3 | $281K | Hold |
1,035
| – | – | 0.01% | 803 |
|
|
2019
Q2 | $285K | Hold |
1,035
| – | – | 0.01% | 798 |
|
|
2019
Q1 | $202K | Buy |
+1,035
| New | +$214K | ﹤0.01% | 1038 |
|
|
2018
Q4 | – | Sell |
-935
| Closed | -$233K | – | 1129 |
|
|
2018
Q3 | $233K | Buy |
+935
| New | +$227K | ﹤0.01% | 1016 |
|
|
2017
Q3 | – | Sell |
-625
| Closed | -$100K | – | 1509 |
|
|
2017
Q2 | $100K | Buy |
625
+385
| +160% | +$62.5K | ﹤0.01% | 1264 |
|
|
2017
Q1 | $37K | Hold |
240
| – | – | ﹤0.01% | 1625 |
|
|
2016
Q4 | $28K | Hold |
240
| – | – | ﹤0.01% | 1814 |
|
|
2016
Q3 | $27K | Sell |
240
-80
| -25% | -$8.43K | ﹤0.01% | 1760 |
|
|
2016
Q2 | $29K | Hold |
320
| – | – | ﹤0.01% | 1619 |
|
|
2016
Q1 | $25K | Sell |
320
-517
| -62% | -$37.2K | ﹤0.01% | 1643 |
|
|
2015
Q4 | $60K | Sell |
837
-765
| -48% | -$54.6K | ﹤0.01% | 1331 |
|
|
2015
Q3 | $118K | Buy |
1,602
+62
| +4% | +$4.44K | ﹤0.01% | 1030 |
|
|
2015
Q2 | $98K | Hold |
1,540
| – | – | ﹤0.01% | 1157 |
|
|
2015
Q1 | $118K | Buy |
1,540
+78
| +5% | +$6.07K | ﹤0.01% | 1067 |
|
|
2014
Q4 | $107K | Buy |
1,462
+502
| +52% | +$35.2K | ﹤0.01% | 1093 |
|
|
2014
Q3 | $55K | Sell |
960
-34
| -3% | -$2.15K | ﹤0.01% | 1370 |
|
|
2014
Q2 | $66K | Sell |
994
-24
| -2% | -$1.53K | ﹤0.01% | 1313 |
|
|
2014
Q1 | $60K | Sell |
1,018
-10
| -1% | -$596 | ﹤0.01% | 1342 |
|
|
2013
Q4 | $54K | Buy |
1,028
+80
| +8% | +$4.21K | ﹤0.01% | 1304 |
|
|
2013
Q3 | $47K | Sell |
948
-12
| -1% | -$577 | ﹤0.01% | 1155 |
|
|
2013
Q2 | $43K | Buy |
+960
| New | +$41.9K | ﹤0.01% | 1136 |
|
Other funds holding IDXX
VCM
VPM
D.A. Davidson & Co's IDXX Position: Q1 2026 in Review
D.A. Davidson & Co increased its Idexx Laboratories (IDXX) stake by 39% in Q1 2026, buying an estimated $523K and bringing the position to 2,923 shares worth $1.64M. The position accounts for 0.01% of the portfolio, ranked #758.
D.A. Davidson & Co first reported a position in IDXX in Q2 2013 and has held it in 44 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- D.A. Davidson & Co held 2,923 shares of Idexx Laboratories worth $1.64M as of Q1 2026.
- D.A. Davidson & Co bought 815 Idexx Laboratories shares in Q1 2026, an estimated $523K.
- Idexx Laboratories made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #758 holding.
- D.A. Davidson & Co first reported a position in Idexx Laboratories in Q2 2013 and has held it in 44 quarters since.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.